Azimycin

Azimycin is an antibacterial drug for systemic use. Macrolide antibiotic used to treat bacterial infections. This preparation is also indicated in lower respiratory tract infections (bronchitis, pneumonia) or infections of the skin and soft tissues. The drug in the form of coated tablets is dispensed in a pharmacy on prescription.

Azimycin, Producer: Polfa Tarchomin

form, dose, packaging availability category the active substance
coated tablets; 125 mg, 250 mg; 500 mg; 3 pieces, 6 pieces prescription drug azithromycin

Azimycin indications for use

The task of Azimycin is to treat the following infections caused by microorganisms sensitive to azithromycin:

  1. lower respiratory tract infections: bacterial bronchitis, interstitial and bronchopneumonia,
  2. upper respiratory tract infections: inflammation of the tonsils, throat, sinuses, acute otitis media,
  3. skin and soft tissue infections, such as erysipelas, impetigo,
  4. secondary pyoderma; migratory erythema (the first symptom of Lyme disease).

Additionally, Azimycin in the form of 250 mg or 500 mg tablets is indicated for the treatment of uncomplicated urethritis and cervicitis caused by chlamydia.

Azimycin and contraindications

A contraindication to taking Azimycin is hypersensitivity to any of the ingredients or other macrolide antibiotics.

Dosage Azimycin

Adults and children weighing more than 45 kg (250 or 500 mg tablets are recommended for this group):

  1. Usually, 500 mg once a day for 1 days or a single dose of 3 mg on the first day, and then 500 mg once a day for 250 consecutive days.
  2. For the treatment of sexually transmitted diseases (uncomplicated infection of the urethra and cervix caused by chlamydia): 1 g once.

Dosage adjustment is not necessary in the elderly.

Children weighing less than 45 kg over 6 months of age (who can swallow a tablet; for the rest of children it is recommended to use an antibiotic suspension):

  1. The usual dose is 10 mg / kg body weight once a day for 1 days.
  2. In case of mild to moderate renal impairment (creatinine clearance greater than 40 ml / min), no dosage adjustment is necessary. There are no data on the use of Azimycin in people with severe renal impairment (creatinine clearance less than 40 ml / min) and caution is advised in such cases.
  3. Caution should be exercised in cases of mild to moderate hepatic impairment. In the event of severe liver dysfunction, the doctor will probably recommend discontinuation of the preparation. It is not recommended to use Azimycin in patients with severe hepatic insufficiency.

Azimycin is intended for oral use. The tablets can be taken with or without food. If gastrointestinal disorders / symptoms occur, it is recommended to take the drug with food. Take once a day.

Azimycin – warnings

  1. The use of Azimycin may rarely be associated with severe hypersensitivity reactions, including potentially life-threatening reactions such as angioedema or anaphylactic reactions.
  2. Caution is advised in patients with impaired liver function or in patients taking concomitant medications that may have hepatotoxic effects (hepatotoxic drugs), and your doctor may recommend regular liver function tests.
  3. It is recommended to exercise caution when taking the drug by people with severe renal impairment.
  4. Do not use Azimycin if there are risk factors such as prolonged QT ECG interval, decreased heart rate (bradycardia), severe heart failure, cardiac arrhythmias, decreased potassium or magnesium levels or other electrolyte disturbances, and if the patient has uses drugs that prolong the QT interval, including antiarrhythmic drugs (class IA and III), cisapride, terfenadine.
  5. Azimycinnie is indicated for the treatment of infected burn wounds.
  6. Medicines should not be used simultaneously with ergot derivatives (e.g. ergotamine) due to the risk of intoxication.
  7. There is no information on the safety and efficacy of Azimycin in infants under 6 months of age.
  8. There is no information available on the safety and efficacy of long-term use of azithromycin.
  9. Pregnant women may only take the medicine if the doctor deems it necessary.
  10. It is recommended not to breastfeed while using Azimycini for 2 days after stopping its use. Please consult your doctor and determine whether breastfeeding can be continued.

Azimycin with other drugs

Tell your doctor if you are taking:

  1. drugs that can prolong the QT interval on the ECG (including class IA antiarrhythmic drugs, e.g. disopyramide and class III drugs, e.g. amiodarone),
  2. terfenadyny,
  3. cyzaprydy,
  4. antacids,
  5. ergotamine derivatives (ergot derivatives),
  6. digoxin
  7. cyclosporins,
  8. nelfinawiru,
  9. anticoagulants (coumarin derivatives, e.g. warfarin),
  10. teofiliny,
  11. didanosine or rifabutin,
  12. his wife
  13. astemizole, triazolam, midazolam and alfentanil.

Azimycin – side effects

The use of Azimycin may cause, among other things: increase in liver enzymes or increase in bilirubin, rarely liver dysfunction (hepatitis, cholestatic jaundice, hepatic necrosis and liver failure, rarely fatal), pancreatitis (rare), headache and dizziness, balance disorder, somnolence, insomnia, seizures, changes in taste, discoloration of the tongue, pseudomembranous inflammation of the intestine (manifested by diarrhea), smell, hearing (hearing damage, deafness, tinnitus), blurred vision, fainting, excessive mobility, nervousness, fatigue and weakness (asthenia), tingling and numbness (paraesthesia).

Before use, read the leaflet, which contains indications, contraindications, data on side effects and dosage as well as information on the use of the medicinal product, or consult your doctor or pharmacist, as each drug used improperly is a threat to your life or health. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.

Leave a Reply